MEG3 and hepatocellular carcinoma: In hepatocellular carcinoma, lncRNA-MEG3 was found to inactivate β-catenin via transcriptionally and post-transcriptionally stimulating the expression of miR-122, thus inhibiting cancer growth in vitro and in vivo [267].